Jpmorgan Chase & CO Neuroone Medical Technologies Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 69 shares of NMTC stock, worth $83. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 57
21.05%
Holding current value
$83
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NMTC
# of Institutions
22Shares Held
2.42MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA920KShares$1.11 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT799KShares$966,5020.05% of portfolio
-
Geode Capital Management, LLC Boston, MA284KShares$343,4640.0% of portfolio
-
Perkins Capital Management Inc150KShares$181,5000.15% of portfolio
-
State Street Corp Boston, MA59.5KShares$71,9930.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $19.6M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...